Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis

M. Mcelroy (Edinburgh, United Kingdom), J. Baily (Edinburgh, United Kingdom), O. Peris Serrano (Edinburgh, United Kingdom), A. Marsden (Edinburgh, United Kingdom), M. Briggs (Harlow, United Kingdom), I. Love (Edinburgh, United Kingdom), S. Madden (Edinburgh, United Kingdom), S. Gandi (Edinburgh, United Kingdom), M. Whitmarsh (Harlow, United Kingdom), A. Young (Harlow, United Kingdom)

Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Session: New mechanistic insights into pulmonary fibrosis
Session type: Thematic Poster
Number: 2422
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Mcelroy (Edinburgh, United Kingdom), J. Baily (Edinburgh, United Kingdom), O. Peris Serrano (Edinburgh, United Kingdom), A. Marsden (Edinburgh, United Kingdom), M. Briggs (Harlow, United Kingdom), I. Love (Edinburgh, United Kingdom), S. Madden (Edinburgh, United Kingdom), S. Gandi (Edinburgh, United Kingdom), M. Whitmarsh (Harlow, United Kingdom), A. Young (Harlow, United Kingdom). Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis. 2422

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019


Late Breaking Abstract - Endothelial Cell-Specific Anticoagulation Reduces Inflammation in a Mouse Model of ALI
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017

Use of Telemetry and Plethysmography to Assess Respiratory Function in Conscious Rats with Bleomycin-Induced Lung Fibrosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

PP212 – The Anti-Fibrotic Drug Nintedanib Promotes Repair Macrophages
Source: ERS Lung Science Conference 2021
Year: 2021

Late Breaking Abstract - ACE2 Overexpression Modulates Nicotine Receptors In Cell Type Specific Manner: Possible Relevance In Covid-19
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021



A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021



A new Humanized Mouse Model for Idiopathic Pulmonary Fibrosis and Effects of Nintedanib Treatment
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018



Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations?
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019

Characterization of the Immune Response in Clinical Sepsis To Identify Potential Therapeutic Targets
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


Physical Training Improves Lung Function and Mechanics and Pulmonary and Systemic Immune Response in Eutrophic Women
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020


High Intensity Resistance Training Improves Respiratory, Peripheral, Quality of Life and Emotional Response in Elderly with Parkinson Disease
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017

Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021



Acetylsalicylic Acid Prevents Intermittent Hypoxia-Induced Vascular Remodeling in a Murine Model of Sleep Apnea
Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia
Year: 2018



Aerobic Exercise Improves Asthma Phenotype in a Model of Severe Asthma: Involvement of Kinins
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021


Resistance Training Alone Improves Lung Inflammation and Respiratory Muscle Strenght but not Lung Function and Mechanics in Mid-Age Women
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020


Creatine Supplementation Augments Chronic Allergic Airway Inflammation and Remodelling: from Mice to Human Evidence
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018


Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Wildfire Smoke Exposure During Infancy Results in Impaired Lung Function
Source: International Congress 2019 – Air pollution and the lungs
Year: 2019

Oral presentation: A New Target and Novel Agent to Prevent Acute Lung Injury
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014